Vaxcyte (PCVX) falls 3.83% on Strong Volume September 17

Equities Staff  |

Vaxcyte Inc (NASDAQ: PCVX) shares fell 3.83%, or $1.01 per share, to close Friday at $25.36. After opening the day at $26.53, shares of Vaxcyte fluctuated between $26.55 and $25.27. 1,128,350 shares traded hands an increase from their 30 day average of 177,197. Friday's activity brought Vaxcyte’s market cap to $1,323,520,369.

Vaxcyte is headquartered in Foster City, California, and employs more than 14000 people.

About Vaxcyte Inc

Vaxcyte is a next-generation vaccine company seeking to improve global health by developing superior and novel vaccines designed to prevent or treat some of the most common and deadly infectious diseases worldwide. The Company’s cell-free protein synthesis platform, comprising the XpressCFTM platform, exclusively licensed from Sutro Biopharma, Inc., together with Vaxcyte’s proprietary know-how, enables the design and production of protein carriers and antigens, the critical building blocks of vaccines, in ways that the Company believes conventional vaccine technologies currently cannot. Vaxcyte’s lead vaccine candidate, VAX-24, is a preclinical, 24-valent broad-spectrum pneumococcal conjugate vaccine (PCV) being developed for the prevention of invasive pneumococcal disease (IPD). Vaxcyte’s pipeline also includes VAX-XP, a PCV with an expanded breadth of coverage of at least 30 strains, including newly emerging strains responsible for IPD and antibiotic resistance; VAX-A1, a prophylactic vaccine candidate designed to prevent Group A Strep infections; and VAX-PG, a therapeutic vaccine candidate designed to slow or stop the progression of periodontal disease by targeting the keystone pathogen responsible for this chronic, oral inflammatory disease.

Visit Vaxcyte Inc’s profile for more information.

About The Nasdaq Stock Market

The Nasdaq Stock Market is a global leader in trading data and services, and equities and options listing. Nasdaq is the world's leading exchange for options volume and is home to the five largest US companies - Apple, Microsoft, Amazon, Alphabet and Facebook.

To get more information on Vaxcyte Inc and to follow the company’s latest updates, you can visit the company’s profile page here: Vaxcyte Inc’s Profile. For more news on the financial markets be sure to visit Equities News. Also, don’t forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Chart is provided by TradingView based on 15-minute-delayed prices. All other data is provided by IEX Cloud as of 8:05 pm ET on the day of publication.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Trending Articles

McDonald's To Offer New Plant-Based Burger in US Restaurants by Beyond Meat
Walgreens Investing Additional $5.2 Billion in Primary Care Provider VillageMD
JPMorgan Misses on Third Quarter Revenue, Beats Earnings Estimates With One-Time Items
BlackRock Beats Q3 Profit Estimates, But Asset Growth Flattens
Emerson Electric To Merge Industrial Software Businesses With Aspen Technology
Facebook Willing To Accept More Oversight and Regulation
Amazon Offering Greater Flexibility for Employees To Work Remotely
California To Ban Sales of Gasoline-Powered Lawn Equipment



Market Movers

Sponsored Financial Content